The results of a study published online and in Circulation indicate that a medical device from Medtronic, Inc., the IN.PACT Admiral drug-coated balloon (DCB), outperformed standard balloon angioplasty in the treatment of symptomatic peripheral artery disease in the upper leg, specifically, the superficial femoral and proximal popliteal arteries.